Apellis Pharmaceuticals sell Lokrim
Start price
07.08.23
/
20%
€18.20
Target price
07.08.24
-
Performance (%)
224.18%
End price
19.01.24
€59.00
Summary
This prediction ended on 19.01.24 with a price of €59.00. The SELL prediction by Lokrim for Apellis Pharmaceuticals was trending in the completely wrong direction and closed with a performance of 224.18%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
According to Lokrim what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Sell Apellis Pharmaceuticals